Dr. Jerome M. Thomas, MD
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Morehouse School of Medicine (2003)
- Years since graduation
- 23
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 690
Licensed in Texas since 2016, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2003Medical school: Morehouse School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
TX license Q7972 (first issued 2016; active) -
Cardiovascular Disease Physician
NJ license 25MA08617900 · PA license MD437691 · TX license Q7972 (first issued 2016; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- St David's Medical Center Austin, TX
- Round Rock Medical Center Round Rock, TX
- Ascension Seton Hays Kyle, TX
- Hill Country Memorial Hospital Fredericksburg, TX
- Columbus Community Hospital Columbus, TX
Medical groups
- St Davids Heart and Vascular PLLC (203 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 690
- Services billed
- 3,912
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 748 | 357 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 638 | 180 |
| Established patient office or other outpatient visit, 40-54 minutes | 358 | 221 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 227 | 180 |
| Critical care, first 30-74 minutes | 199 | 46 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 153 | 136 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 102 | 74 |
| Insertion of tube in right heart chambers for measurement | 98 | 86 |
| Test for exercise-induced lung stress | 94 | 80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 86 | 84 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Austin, TX | 415 |
| Entresto (sacubitril/valsartan) Other prescribers in Austin, TX | 414 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Austin, TX | 379 |
| Torsemide Other prescribers in Austin, TX | 367 |
| Potassium Chloride Other prescribers in Austin, TX | 352 |
| Carvedilol Other prescribers in Austin, TX | 320 |
| Furosemide Other prescribers in Austin, TX | 289 |
| Metoprolol Succinate Other prescribers in Austin, TX | 220 |
| Digoxin Other prescribers in Austin, TX | 164 |
| Jardiance (empagliflozin) Other prescribers in Austin, TX | 157 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 22 companies reported 178 payments worth $58,179 in total to this clinician.
| Abbott Laboratories | $40,765 |
|---|---|
| Actelion Pharmaceuticals US, Inc. | $10,164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,147 |
| Lilly USA, LLC | $1,040 |
| Abiomed | $560 |
| Atricure, Inc. | $226 |
| Cvrx, Inc. | $217 |
| Pfizer Inc. | $196 |
| Consulting Fee | $34,763 |
|---|---|
| Compensation for services other than consulting (speaking, faculty) | $13,645 |
| Travel and Lodging | $5,734 |
| Food and Beverage | $4,017 |
| Education | $20.22 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Dec 24, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $6,075 |
| Abbott Laboratories Aug 28, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $6,075 |
| Abbott Laboratories Nov 5, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $6,075 |
| Abbott Laboratories Aug 28, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $3,038 |
| Actelion Pharmaceuticals US, Inc. Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $2,940 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $2,850 |
| Abbott Laboratories May 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $2,700 |
| Actelion Pharmaceuticals US, Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $2,520 |
| Actelion Pharmaceuticals US, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $2,520 |
| Abbott Laboratories Apr 29, 2025 | Travel and Lodging CARDIOMEMS · Structural Heart · travel to San Angelo, TX · in-kind | $2,363 |
All 31 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Abbott Laboratories Dec 24, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $6,075 |
| Abbott Laboratories Dec 24, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,350 |
| Abbott Laboratories Nov 5, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $6,075 |
| Abbott Laboratories Nov 5, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,350 |
| Lilly USA, LLC Nov 5, 2025 | Compensation for services other than consulting (speaking, faculty) | $390 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 17, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $2,850 |
| Abbott Laboratories Oct 9, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,350 |
| Abbott Laboratories Oct 9, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $675 |
| Actelion Pharmaceuticals US, Inc. Oct 3, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $2,940 |
| Actelion Pharmaceuticals US, Inc. Oct 2, 2025 | Travel and Lodging UPTRAVI; OPSUMIT · Cardiology · travel to Fort Worth, TX · in-kind | $1,101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · DIABETES | $1,040 |
| Actelion Pharmaceuticals US, Inc. Sep 19, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $735 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 3, 2025 | Education Kerendia · Cardio-Renal · in-kind | $20.22 |
| Abbott Laboratories Aug 28, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $6,075 |
| Abbott Laboratories Aug 28, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $3,038 |
| Actelion Pharmaceuticals US, Inc. Aug 22, 2025 | Travel and Lodging UPTRAVI; OPSUMIT · Cardiology · travel to Fort Worth, TX · in-kind | $5.50 |
| Actelion Pharmaceuticals US, Inc. Jun 19, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $2,520 |
| Abbott Laboratories May 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $2,700 |
| Abbott Laboratories May 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,013 |
| Abbott Laboratories May 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,013 |
| Abbott Laboratories May 29, 2025 | Travel and Lodging CARDIOMEMS · Structural Heart · travel to Austin, TX · in-kind | $911 |
| Abbott Laboratories May 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $338 |
| Abbott Laboratories May 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $338 |
| Abbott Laboratories Apr 29, 2025 | Travel and Lodging CARDIOMEMS · Structural Heart · travel to San Angelo, TX · in-kind | $2,363 |
| Abbott Laboratories Apr 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,688 |
| Abbott Laboratories Apr 29, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $1,013 |
| Lilly USA, LLC Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) JARDIANCE · Diabetes | $650 |
| Abbott Laboratories Mar 18, 2025 | Consulting Fee CARDIOMEMS · Structural Heart | $675 |
| Actelion Pharmaceuticals US, Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) UPTRAVI; OPSUMIT · Cardiology | $2,520 |
| Abbott Laboratories Jan 9, 2025 | Travel and Lodging CARDIOMEMS · Structural Heart · travel to Austin, TX · in-kind | $1,345 |
| Abbott Laboratories Jan 9, 2025 | Travel and Lodging CARDIOMEMS · Structural Heart · travel to Austin, TX · in-kind | $9.02 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,315 in research payments for these studies, mostly to the institutions running them.
- NCT06526195--Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Abbott Laboratories
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.